O2 RegenTech
company
About
O2 RegenTech is commercializing cost-effective, easy-to-use wound care solutions.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $600K
- Industries
- Clinical Trials,Commercial,Medical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
O2 RegenTech LLC is commercializing cost-effective, easy-to-use wound care solutions. Our proprietary, patented technology is used in our initial product offering, OXAID™, as an oxygenating, moist, and antimicrobial dressing to promote and accelerate chronic wound healing.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$600K
O2 RegenTech has raised a total of
$600K
in funding over 2 rounds. Their latest funding was raised on
Jan 26, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 26, 2017 | Grant | $600K | 2 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
O2 RegenTech has made 1 investments. Their most recent investment was on
Jun 14, 2021, when Convosight raised $9M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 14, 2021
Convosight
|
Series A | $9M | SaaS | — |
Investors
Number of Lead Investors
Number of Investors
—
2
O2 RegenTech is funded by 2 investors.
National Institutes of Health
and National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
National Science Foundation
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
